Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 17, 2026 | Capital Blue Cross | Off-Label Use of Medications and other InterventionsPayerPolicy · CAPBLUE-MP-2.103 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Occipital Nerve StimulationPayerPolicy · CAPBLUE-MP-2.372 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Nonpharmacologic Treatment of RosaceaPayerPolicy · CAPBLUE-MP-2.071 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Noninvasive Imaging for the Evaluation and Monitoring of Patients with Chronic Liver DiseasePayerPolicy · CAPBLUE-MP-2.252 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Noninvasive Fetal RHD Genotyping Using Cell-Free Fetal DNAPayerPolicy · CAPBLUE-MP-2.261 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Noncontraceptive Use of Intrauterine Devices (IUDs)PayerPolicy · CAPBLUE-MP-7.026 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Non-Emergent Ground Transport ServicesPayerPolicy · CAPBLUE-MP-3.009 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Next-Generation Sequencing For The Assessment of Measurable Residual DiseasePayerPolicy · CAPBLUE-MP-2.379 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Neuromuscular and Functional Neuromuscular Electrical StimulationPayerPolicy · CAPBLUE-MP-6.051 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Neural TherapyPayerPolicy · CAPBLUE-MP-8.012 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Negative Pressure Wound Therapy in the Outpatient SettingPayerPolicy · CAPBLUE-MP-4.004 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Navigated Transcranial Stimulation (nTMS)PayerPolicy · CAPBLUE-MP-2.094 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Multimarker Serum Testing Related to Ovarian CancerPayerPolicy · CAPBLUE-MP-2.270 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Multicancer Early Detection TestingPayerPolicy · CAPBLUE-MP-2.387 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Molecular Testing in the Management of Pulmonary NodulesPayerPolicy · CAPBLUE-MP-2.375 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Molecular Testing for The Management of Pancreatic Cysts and Solid Pancreaticobiliary LesionsPayerPolicy · CAPBLUE-MP-2.266 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Molecular Testing for Germline Variants Associated with Ovarian Cancer (BRIP1, RAD51C, RAD51D, NBN)PayerPolicy · CAPBLUE-MP-2.377 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Molecular Panel Testing of Cancers to Identify Targeted TherapiesPayerPolicy · CAPBLUE-MP-2.259 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Molecular Markers in Fine Needle Aspirates of the ThyroidPayerPolicy · CAPBLUE-MP-2.275 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Minimally Invasive Ablation Procedures for Morton and Other Peripheral NeuromasPayerPolicy · CAPBLUE-MP-2.084 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Microwave Tumor AblationPayerPolicy · CAPBLUE-MP-2.090 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Medical Treatments of Autism Spectrum DisordersPayerPolicy · CAPBLUE-MP-2.304 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Medical NecessityPayerPolicy · CAPBLUE-MP-4.003 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Medical Management of Obstructive Sleep Apnea SyndromePayerPolicy · CAPBLUE-MP-6.064 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Mechanical Insufflation Exsufflation DevicePayerPolicy · CAPBLUE-MP-6.022 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Measurement of Exhaled Nitric Oxide in the Diagnosis and Management of Asthma and Other Respiratory DisordersPayerPolicy · CAPBLUE-MP-4.038 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Manual Wheelchairs and AccessoriesPayerPolicy · CAPBLUE-MP-6.059 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Magnetic Resonance-Guided Focused UltrasoundPayerPolicy · CAPBLUE-MP-5.053 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux DiseasePayerPolicy · CAPBLUE-MP-1.145 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Lysis of Epidural AdhesionsPayerPolicy · CAPBLUE-MP-6.027 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Lung and Lobar Lung TransplantPayerPolicy · CAPBLUE-MP-9.015 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Lower Limb ProsthesesPayerPolicy · CAPBLUE-MP-6.042 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Low Level Laser TherapyPayerPolicy · CAPBLUE-MP-1.097 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Low Intensity Pulsed Ultrasound Fracture Healing DevicePayerPolicy · CAPBLUE-MP-6.021 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Liver Transplant and Combined Liver-Kidney TransplantPayerPolicy · CAPBLUE-MP-9.006 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Light TherapiesPayerPolicy · CAPBLUE-MP-2.046 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Laser Treatment for Vulvovaginal Atrophy and Vaginal RejuvenationPayerPolicy · CAPBLUE-MP-4.047 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Laboratory and Genetic Testing for Use of 5-Flourouracil in Patients with CancerPayerPolicy · CAPBLUE-MP-2.354 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Knee BracesPayerPolicy · CAPBLUE-MP-6.012 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Kidney Transplants, Pancreas Transplants, and Simultaneous Kidney/Pancreas TransplantPayerPolicy · CAPBLUE-MP-9.005 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | JAK2, MPL, and CLR Mutation Analysis in Myeloproliferative NeoplasmsPayerPolicy · CAPBLUE-MP-2.281 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Isolated Small Bowel Transplant and Small Bowel/Liver and Multivisceral TransplantPayerPolicy · CAPBLUE-MP-9.013 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Islet TransplantationPayerPolicy · CAPBLUE-MP-9.012 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney or LungPayerPolicy · CAPBLUE-MP-1.162 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Investigational Miscellaneous Genetic and Molecular TestsPayerPolicy · CAPBLUE-MP-2.277 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Invasive Prenatal (Fetal) Diagnostic TestingPayerPolicy · CAPBLUE-MP-2.278 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Intravitreal and Punctum Corticosteroid ImplantsPayerPolicy · CAPBLUE-MP-2.159 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Intravenous Chelation TherapyPayerPolicy · CAPBLUE-MP-4.005 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Intraoperative Neurophysiologic Monitoring (Sensory Evoked Potentials, Motor Evoked Potentials, EEG Monitoring)PayerPolicy · CAPBLUE-MP-2.030 | Criteria changed |
|---|
| May 17, 2026 | Capital Blue Cross | Intraocular Radiotherapy for Age-Related Macular DegenerationPayerPolicy · CAPBLUE-MP-2.389 | Criteria changed |
|---|